Revolution Medicines (RVMD) Return on Invested Capital (2020 - 2024)
Historic Return on Invested Capital for Revolution Medicines (RVMD) over the last 5 years, with Q4 2024 value amounting to 0.36%.
- Revolution Medicines' Return on Invested Capital changed 0.0% to 0.36% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.36%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.34% for FY2024, which is 500.0% up from last year.
- Per Revolution Medicines' latest filing, its Return on Invested Capital stood at 0.36% for Q4 2024, which was down 0.0% from 0.41% recorded in Q3 2024.
- Revolution Medicines' Return on Invested Capital's 5-year high stood at 0.2% during Q2 2021, with a 5-year trough of 0.42% in Q3 2022.
- Over the past 5 years, Revolution Medicines' median Return on Invested Capital value was 0.35% (recorded in 2023), while the average stood at 0.33%.
- As far as peak fluctuations go, Revolution Medicines' Return on Invested Capital tumbled by -1700bps in 2022, and later soared by 300bps in 2024.
- Quarter analysis of 5 years shows Revolution Medicines' Return on Invested Capital stood at 0.23% in 2020, then decreased by -14bps to 0.26% in 2021, then plummeted by -47bps to 0.38% in 2022, then grew by 4bps to 0.36% in 2023, then rose by 1bps to 0.36% in 2024.
- Its last three reported values are 0.36% in Q4 2024, 0.41% for Q3 2024, and 0.36% during Q2 2024.